MedPath

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Not yet recruiting
Conditions
Healthy
Celiac
Dermatologic
Lupus
Chronic
Kidney Disease
Registration Number
NCT07128966
Lead Sponsor
Joined Bio
Brief Summary

This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.

Detailed Description

Primary: The primary objective of this study is to connect participants with specific health profiles, along with biospecimens and associated de-identified health data, to scientific researchers who are searching for new diagnostics and treatments for a wide array of conditions. This will accelerate medical discovery by connecting medical research with the power of patient participation.

Secondary: The secondary objective of this study is to allow participants with specific health profiles, along with their de-identified health data, to help further the cause of medicine generally through interviews, surveys, and other minimal risk research activities desired by life science organizations.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100000
Inclusion Criteria
  • Male or female, that are adults [have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico].
  • Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
  • Be willing to comply with all study procedures and be available for the duration of the study.
  • Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
  • Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.
Exclusion Criteria
  • Unable to meet the Inclusion Criteria listed above.
  • Prisoners or children
  • Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Observation for biomarker identification10 years

There is no defined study outcome. Rather this is an observational study of multiple participant populations that hopes to identify new biomarkers, treatments and/or diagnostic applications.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Joined Bio

🇺🇸

Lexington, Massachusetts, United States

Joined Bio
🇺🇸Lexington, Massachusetts, United States
Jill Mullan
Contact
978-219-4496
jmullan@joined.bio
Chris Ianelli
Contact
978-219-4496
cianelli@joined.bio
Chris Ianelli, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.